Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2

By S. Mittal, Zhanghua Wu, J. Neelavalli, E. Haacke. American Journal of Neuroradiology, 2008

771 citations recorded by the source corpus.

SUMMARY: Susceptibility-weighted imaging (SWI) has continued to develop into a powerful clinical tool to visualize venous structures and iron in the brain and to study diverse pathologic conditions. SWI offers a unique contrast, different from spin attenuation, T1, T2, and T2* (see Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1). In this clinical review (Part 2), we present a variety of neurovascular and neurodegenerative disease applications for SWI, covering trauma, stroke, cerebral amyloid angiopathy, venous anomalies, multiple sclerosis, and tumors. We conclude that SWI often offers complementary information valuable in the diagnosis and potential treatment of patients with neurologic disorders.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/d44ccefacf59ca4bb828f3ecda58df83a5a02494

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Wei Li
2. Bing Wu
3. Chunlei Liu
4. Tian Liu

Citations in the corpus

• Overview of quantitative susceptibility mapping (2017, neutral): “χb 1⁄4 hct Y χoxy þ 1 Y ð Þ χdeoxy þ 1 hct ð Þ χplasma [23]”
• Quantitative Susceptibility Mapping of Human Brain Reflects Spatial Variation in Tissue Composition (2011, background): “The phase information present in MRI images are typically discarded except in a limited number of cases such as the measuring of flow in angiography, enhancing image contrast in susceptibility weighted images and temperature mapping (Gatehouse et al., 2005; Haacke et al., 2009, 2004; Mittal et al., ”